BRIEF-SIFI s.p.a., Knight Therapeutics in canadian license agreement for NETILDEX(tm)

Tue Aug 2, 2016 5:59pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Aug 2 (Reuters) - Knight Therapeutics Inc

* SIFI s.p.a. and Knight Therapeutics announce canadian license agreement for NETILDEX(tm)

* Knight will also handle all ongoing regulatory and commercial activities for netildex(tm) in canada. Source text for Eikon: Further company coverage: